The Global Pharmaceutical Grade Sodium Bicarbonate Market is valued at USD 265.3 million in 2023 and is projected to register significant growth at a CAGR of 3.5% to reach a market valuation of USD 372.4 million by the end of 2033.
| Attribute | Details |
|---|---|
| Market Size (2023) | USD 265.3 Million |
| Forecasted Market Size (2033) | USD 372.4 Million |
| Value CAGR (2023 to 2033) | 3.5% |
| Collective Value Share: Top 5 Countries (2023E) | 55-59% |
According to this latest research conducted by Future Market Insights, global market revenue totaled USD 256.0 million in 2022. The market is reliant on the pharmaceutical industry as a pH buffering agent, for electrolyte replenishing, as a systemic alkalizer, and in topical cleansing solutions. It is extensively used as an active pharmaceutical ingredient and excipient. The demand from hospitals, the personal care industry, and healthcare institutions is expected to benefit the global market.
| Market Statistics | Details |
|---|---|
| January–June (H1), 2021 (A) | 2.7% |
| July–December (H2), 2021 (A) | 3.3% |
| January–June (H1),2022 Projected (P) | 3.0% |
| January–June (H1),2022 Outlook (O) | 3.4% |
| July–December (H2), 2022 Outlook (O) | 3.1% |
| July–December (H2), 2022 Projected (P) | 3.6% |
| January–June (H1), 2023 Projected (P) | 3.6% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | (+) 40 ↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | (+) 70↑ |
| BPS Change: H2, 2022 (O) - H2, 2022 (P) | (-) 50 ↓ |
| BPS Change: H2, 2022 (O) - H2, 2021 (A) | (-) 20 ↓ |
The above chart depicts changes in the market owing to several global economic factors. The half-yearly analysis of the market provides investors with a short performance review for that specific period. Pharmaceutical industries were adapting to the immediate concerns brought on by supply chain disruption and the rapid need to modify healthcare procedures resulting in the loss of 50 BPS points in the year 2022. The market witnessed relatively lower demand owing to a disrupted supply of active chemicals and materials mainly from china which impacted the overall market.
Considerable growth in the pharmaceutical industry along with the increasing sales of chemicals is expected to boost the demand over the projected period. As per the latest estimations released by Future Market Insights (FMI), global sales is anticipated to increase swiftly between 2023 and 2033, creating an absolute growth opportunity of USD 108.4 million.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The pharmaceutical Industry is the key consumer for sodium bicarbonate. The Covid-19 outbreak forced various pharma companies to shift their operation methods. The sudden spur in the adoption of new technologies and innovation to support virtual work as well as research and development efforts on possible treatment plans to balance the supply chain for medicines during a crisis has impacted the overall market during the pandemic.
The market is estimated to grow at 3.5% CAGR over the coming decade owing to advancements in research and developments, the transformation of digital platforms and IT is currently the top strategic priority for pharmaceutical companies and is expected to continue to be so in the future.
Pharmaceutical Grade Sodium Bicarbonate is expected to register significant growth during the assessment period. Based on geography East Asia is estimated to dominate the market owing to the presence of a leading manufacturing units of leading pharmaceutical companies in China.
Over the past five years, numerous developments in the market have taken place. Leading Companies devised their plans to fend off possible threats and seize the medium- and long-term possibilities presented by this shifting environment and focused on the development of soda bicarbonate drugs with a fine grade for the treatment of a wide range of diseases.
Active pharmaceutical ingredients are the chemical compounds in medicines that have a significant effect on the body, such drugs containing soda-bicarbonate help in activate an anti-inflammatory pathway and prevent autoimmune diseases. Some medicines called OTC (over-the-counter) medicines contained pharma-grade baking soda as an active pharma ingredient.
Over-the-counter drugs are medicines that can be bought without a prescription as per the guidelines issued by FDA (Food and Drug Administration), which considers them safe for use without medical supervision. These drugs are used to treat various generic health problems such as sleeping-related problems, cough and cold, pain, smoking cessation, itches, weight problems, tooth decay, gastrointestinal problems, and various others.
The top five over-the-counter categories include — cough-cold and allergy, vitamins, weight loss and nutrition, pain relief, and digestives — which collectively accounted for a significant share of all over-the-counter sales in 2022.
Antacids are one of the most popular over-the-counter medicines. Consistent growth in sales of antacids, baking soda or sodium bicarbonate is the key ingredient for any kind of antacids. Steady growth in sales of antacids is promoting the demand with consistent growth rates.
Awareness and media advertising made people aware about self-medication for occasional heartburn and acidity and the availability of antacids in over-the-counter (OTC) sales has emerged as one of the prime factors for antacids and similar products’ growth.
Principal Consultant
The production of many different products involves the use of sodium carbonate in a range of chemical processes, particularly acid-base reactions. They could be found in many personal care products, including toothpaste, which temporarily raises the pH level of the mouth by acting as abrasives or foaming agents.
Hair dyes also contain pharma-grade sodium carbonate. It eliminates oil and grime from the skin and hair while also assisting with pH control. Pharma-grade baking soda is used by several organizations in the personal care industry. For instance, Church and Dwight Co. Inc. utilizes sodium carbonate in their dental pastes whereas Proctor and Gamble Co. uses it in their men's hair color products.
The growing demand from the personal care and cosmetics industry for active ingredients in formulations is expected to boost the demand for pharma-grade baking soda during the forecast period.
Active pharmaceutical ingredients are the leading application segment of the sodium bicarbonate market and are estimated to dominate the global market, accounting for nearly 33.2% of the market by 2033.
An active pharmaceutical ingredient, or API, is the main component of medicine. It is mostly accountable for enhancing the drug's ability to treat diseases and their associated symptoms. Several organizations in the pharmaceutical industry utilize sodium carbonate as API to improve the efficacy of their products.
The urgent need for small molecules which are considered to be an integral part of prescription drugs for secondary treatment issued by a specialist is another vital factor that is likely to bolster the sales of active pharma ingredients.
On the basis of grade, the fine grade segment is the most preferred grade of baking soda and is estimated to dominate the global market, accounting for nearly 20.7% of the market by 2033.
Unlike traditional medicines, baking soda tablets are fast-acting antacids. They are used for instant relief in case of heartburn and indigestion. These tablets can easily dissolve in water before consumption owing to the presence of fine particles of soda bi-carbonate.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | United States |
|---|---|
| Market Share (2023) | 21.9% |
| Market Share (2033) | 20.6% |
| BPS Analysis | -128.0 |
| Country | China |
|---|---|
| Market Share (2023) | 23.8% |
| Market Share (2033) | 25.6% |
| BPS Analysis | +177.6 |
| Country | Germany |
|---|---|
| Market Share (2023) | 8.1% |
| Market Share (2033) | 8.2% |
| BPS Analysis | +10 |
| Country | Japan |
|---|---|
| Market Share (2023) | 5.5% |
| Market Share (2033) | 5.2% |
| BPS Analysis | -28.4 |
| Country | India |
|---|---|
| Market Share (2023) | 3.3% |
| Market Share (2033) | 3.5% |
| BPS Analysis | +23.4 |
China holds more than 23.8% of the volume and value share in the global market which is likely to remain unchanged through the forecast period. Key players from China have significant opportunities to leverage revenue generation in the country.
Chinese pharmaceutical manufacturers have largely focused on the production of basic chemicals, intermediates, and active pharmaceutical ingredients (APIs), with roughly 4,000 API manufacturers in the country. Thus, an increase in the production of active pharmaceutical ingredients drives the demand for the soda-bicarbonate market.
In India, there is a high concentration of manufacturers of pharma drugs and vaccines, which is contributing to the growth of the market in this region at a CAGR of 3.8% through 2033.
The generic medications produced in India and distributed internationally offer safety and quality. India accounts for the second-most portion of the global workforce in biotechnology and pharmaceuticals. The biotechnology sector in India, which includes biopharmaceuticals, services, bio-agriculture, bio-industry, and bioinformatics, is predicted to develop at an average pace of 30% and reach USD 100 billion by 2025.
Various online or telemarketing campaigns is informing Indian consumers towards the ineffectiveness of traditional home remedies and generic solutions like lime juice. Such innovative advertising initiatives by well-known businesses is expected to increase product consumption in India.
Germany holds a 33.9% share in the Western Europe market, while also holding a leading position in global market. Germany is the ideal location for pharmaceutical research and development, manufacture, and sales due to cutting-edge research and innovation facilities, long history as the "world's pharmacy," and consistently high demand for healthcare products which is expected to propel the demand for pharmaceutical-grade sodium bicarbonate in the country.
According to The Observatory of Economics, in 2020, Germany exported USD116 million in baking, making it the 2nd largest exporter of baking soda in the world. The surge in the production of baking soda in Germany is expected to boost demand for the market during the forecast period.
The market is concentrated by leading manufacturers. Tier-I companies are focused on developing high-quality pharma-grade-baking soda and developing technologies for mining. Leading players in the market are focusing on generating revenue by exploring potential applications. Players are expanding their geographical boundaries to them expand their consumer base.
Key Developments:
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 3.5% from 2023 to 2033 |
| Base Year for Estimation | 2023 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USA Dollar Million, Volume in Tons, and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Market Segments Covered | Grade; Application; Region |
| Regions Covered | North America; Latin America; Eastern Europe; Western Europe; South Asia and Pacific; China; India; Japan; Middle East and Africa |
| Key Countries Covered | United States; Canada; Mexico; Brazil; China; Japan; South Korea; India; Association of South East Asian Nations; Germany; France; Italy; Spain; BENELUX; United Kingdom; Russia; The Gulf Co-operation Council Countries; Türkiye; Northern Africa; South Africa |
| Key Companies Profiled | Tata Chemicals; Novacarb (Novacap Group); Dr. Paul Lohmann GmbH KG; GHCL Limited; CIECH S.A.; Natural Soda LLC; Jost Chemical Co.; Tornox Alkali Corporation |
| Customization and Pricing | Available upon Request |
The market registered 4.1% HCAGR from 2013 to 2021.
The market is estimated to USD 315.4 million by 2028.
Through 2028, the market is anticipated to expand at a 3.5% CAGR.
The API category is expected to capture 31.9% of the market share.
The fine sector is projected to maintain its lead.
1. Executive Summary | Pharmaceutical Grade Sodium Bicarbonate Market 2. Market Overview 3. Key Market Trends 4. Key Success Factors 5. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033 6. Global Market - Pricing Analysis 7. Global Market Demand (in Value or Size in USD Million) Analysis 2018 to 2022 and Forecast, 2023 to 2033 8. Market Background 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Grade 9.1. Fine 9.2. Coarse 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Application 10.1. API 10.2. Excipients 10.3. Antacids 10.4. Haemodialysis 10.5. Tablet Coating 10.6. Toothpaste 10.7. Others 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 11.1. North America 11.2. Latin America 11.3. Eastern Europe 11.4. Western Europe 11.5. South East Asia and Pacific 11.6. China 11.7. India 11.8. Japan 11.9. Middle East and Africa 12. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16. China Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17. Japan Market Analysis 2018 to 2022 and Forecast 2023 to 2033 18. India Market Analysis 2018 to 2022 and Forecast 2023 to 2033 19. South East Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033 20. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 21. Market Structure Analysis 22. Competition Analysis 22.1. Solvay SA 22.2. Tata Chemicals 22.3. Novacarb (Novacap Group) 22.4. Dr. Paul Lohmann GmbH KG 22.5. GHCL Limited 22.6. CIECH S.A. 22.7. Natural Soda LLC 22.8. Jost Chemical Co. 22.9. Tornox Alkali Corporation 23. Assumptions and Acronyms Used 24. Research Methodology
Chemicals & Materials
July 2023
REP-GB-1701
333 pages
Explore Chemicals & Materials Insights
View Reports
Pharmaceuticals Grade Sodium Bicarbonate Market
